companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

PHYSIOTHERAPIE PHYSIO SANTE INC

VICTORIAVILLE-Canada

Company Name:
Corporate Name:
PHYSIOTHERAPIE PHYSIO SANTE INC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 565 Boul Des Bois-Francs S,VICTORIAVILLE,QC,Canada 
ZIP Code:
Postal Code:
G6P 
Telephone Number: 8193573338 
Fax Number: 8194779033 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
54660 
USA SIC Description:
CLINICS & MEDICAL CENTERS 
Number of Employees:
 
Sales Amount:
Less than $500,000 
Credit History:
Credit Report:
Unknown 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
PHYSIOTHERAPIE VICTORIAVILLE &
PHYSIOTHERAPIE VICTORIAVILLE
PHYSIOTHERAPIE PHYSIO-SANTE
Next company profile:
PHYSIOTHERAPIE DES BOIS FRANCS INC
PHYSIOTHERAPIE DES BOIS-FRANCS
PHOTOGRAPHES BOURRET INC










Company News:
  • ZYPREXA (olanzapine) Label - Food and Drug Administration
    None with ZYPREXA monotherapy When using ZYPREXA and fluoxetine in combination, also refer to the Contraindications section of the package insert for Symbyax® (4) When using ZYPREXA in combination with lithium or valproate, refer to the Contraindications section of the package inserts for those products (4)
  • Olanzapine Injection: Package Insert Prescribing Info
    Olanzapine Injection package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
  • for intramuscular use powder, Olanzapine for Injection,
    When using olanzapine for injection in combination with lithium or valproate, the prescriber should refer to the Warnings and Precautions section of the package inserts for lithium or valproate [see Drug Interactions (7)]
  • ZYPREXA INTRAMUSCULAR- olanzapine injection, powder, for solution TYA . . .
    ZYPREXA (olanzapine) is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions ( , ) and Patient Counseling Information ( )] 5 15 1217 2 When using ZYPREXA and fluoxetine in combination, also refer to the Boxed Warning section of the package insert for Symbyax
  • Eli Lilly and Company
    Other Concomitant Drug Therapy: When using olanzapine in combination with lithium or valproate, refer to the Drug Interactions sections of the package insert for those products
  • Zyprexa (Eli Lilly and Company): FDA Package Insert
    ZYPREXA (olanzapine) is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5 1), Use in Specific Populations (8 5), and Patient Counseling Information (17)] When using ZYPREXA and fluoxetine in combination, also refer to the Boxed Warning section of the package insert for Symbyax
  • PV 5197 AMP ZYPREXA - Food and Drug Administration
    The following findings are based on premarketing trials of (1) oral olanzapine for schizophrenia, bipolar mania, a subsequent trial of patients having various psychiatric symptoms in association with Alzheimer’s disease, and premarketing combination trials, and (2) intramuscular olanzapine for injection in agitated patients with schizophrenia
  • Zyprexa: Package Insert Prescribing Information - Drugs. com
    Zyprexa package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
  • NDC Package 0002-7597-01 Zyprexa Intramuscular
    The NDC Packaged Code 0002-7597-01 is assigned to a package of 1 vial in 1 carton 2 ml in 1 vial of Zyprexa Intramuscular, a human prescription drug labeled by Eli Lilly And Company The product's dosage form is injection, powder, for solution and is administered via intramuscular form This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per
  • PRODUCT MONOGRAPH - Eli Lilly and Company
    Patients receiving intramuscular olanzapine should be closely observed for hypotension including postural hypotension, bradyarrhythmia and or hypoventilation, particularly for the first 2 to 4 hours following injection




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer